Temsirolimus

Temsirolimus

收藏
  • ¥100
  • Gene Operation
  • USA
  • IPA1022-0010MG
  • 2025年11月09日
    avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 技术资料
    • 保质期

      2 years

    • 英文名

      Temsirolimus

    • 库存

      10

    • 供应商

      上海伟进生物科技有限公司

    • CAS号

      162635-04-3

    • 保存条件

      -20℃

    • 规格

      10mg

    Biological Activity

    Temsirolimus is the active ingredient sold under the brand name of drug Torisel®, which has been approved in some countries for the treatment of renal cell carcinoma (RCC). [Note: Temsirolimus sold by Gene Operation is for scientific research use only, not for human and veterinary use.]

    Temsirolimus (CCI-779), a dihydroxymethyl propionic acid ester of rapamycin, is an effective inhibitor of mTOR developed for intravenous use in cancer chemotherapy. CCI-779 has displayed anticancer activity alone or in combination with cytotoxic agents in a variety of preclinical models such as glioblastoma, rhabdomyosarcoma, neuroectodermal tumour such as prostate, pancreatic and breast cancer cells [1-3] and is being evaluated in phase II clinical trials for some cancers [4-5]. In a panel of eight breast cancer lines, six of which are sensitive (IC50 ≤50 nM) and two lines are resistant (IC50>1.0 μM) to CCI-779. Sensitive lines are estrogen dependent (MCF-7, BT-474, T-47D), or lacked expression of the tumor suppressor PTEN (MDA-MB-468, BT-549), and/or overexpressed the Her-2/neu oncogene (SKBR-3, BT-474). Resistant lines (MDA-MB-435,MDA-MB-231) share none of these properties. CCI-779 (50 nM) suppresses mTOR function in both a sensitive and a resistant line [6]. In combination with MOR antagonist Methylnaltrexone (MNTX), CCI-779 enhances inhibition of VEGF-induced EC proliferation and migration with an IC50shift from ~10 nM to ~1 nM and from ~50 to ~10 nM respectively [7]. A p70(s6) kinase assay in PBMCs is currently being incorporated in Phase I and II studies with CCI-779 to determine its relationship with dose and plasma concentration of the agent and its value as a predictor of treatment efficacy [8].

    Chemical Properties

    Cas No.: 162635-04-3

    M. Wt.: 1030.29

    Formula: C56H87NO16

    Purity: >99%

    Synonym: cell cycle inhibitor 779, CCI-779, Torisel®

    Chemical Name: Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate

    Appearance: White to off-white solid

    Solubility: Soluble in DMSO (200 mg/ml) or Ethanol (200 mg/ml), very poorly soluble in water.

    Storage: Store solid at -20 ºC for the stability of 2 years.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥6075
    上海冠东生物科技有限公司
    2025年12月16日询价
    ¥379
    上海伟进生物科技有限公司
    2025年11月10日询价
    ¥2823
    上海研卉生物科技有限公司
    2025年07月30日询价
    ¥110
    北京百奥莱博科技有限公司
    2025年07月15日询价
    Temsirolimus
    ¥100